Full Year 2024 Results Key Financial Results Revenue: US$5.78b (down 4.9% from FY 2023).

Chemours, a leader in titanium dioxide sector, also excels in new refrigerants like Opteon due to regulatory changes. See why ...

The Chemours Company CC reported a net loss of $8 million or 5 cents per share for fourth-quarter 2024 compared with the year ...

Chemours Co. has initiated a strategic review of its European fluoropolymer production assets, including plants in Mechelen, ...

Chemours’s ( NYSE: CC) stock on Tuesday rose as much as 4.1% after the chemicals maker reported a smaller loss for the fourth ...

Q4 2024 Earnings Call Transcript February 18, 2025 The Chemours Company beats earnings expectations. Reported EPS is $0.11, ...

Strategic Financial Concepts LLC purchased a new stake in shares of The Chemours Company (NYSE:CC – Free Report) during the ...

BMO Capital analyst John McNulty lowered the firm’s price target on Chemours (CC) to $27 from $34 and keeps an Outperform rating on the shares ...

In a report released yesterday, Arun Viswanathan from RBC Capital maintained a Buy rating on Chemours Company (CC – Research Report), with a ...

Chemours Company reports Q4 net sales of $1.359 billion, in line with consensus. Adjusted EBITDA improved 2% Y/Y. FY25 ...

I would like to welcome everyone to The Chemours Company fourth-quarter 2024 results conference call. [Operator instructions] ...

The Chemours Company CC reported a net loss of $8 million or 5 cents per share for fourth-quarter 2024 compared with the year-ago quarter's loss of $18 million or 12 cents. Barring one-time items ...